Cardiovascular system

An update on managing patients with atrial fibrillation

Most patients with atrial fibrillation can be managed in primary...

August 2017

The safe and effective use of dabigatran and warfarin in primary care

Patients taking oral anticoagulants require appropriate management...

August 2017

Beta-blockers for cardiovascular conditions: one size does not fit all patients

Metoprolol succinate accounts for almost three-quarters of the...

July 2017

Targeted testing for abdominal aortic aneurysm

A recently published study from the University of Otago provides...

October 2016

Amiodarone brand-change and a reminder on patient monitoring

Two brands of amiodarone are currently subsidised in New Zealand;...

October 2016

Out-of-clinic blood pressure testing in primary care

Out-of-clinic blood pressure monitoring is increasingly regarded...

May 2016

Managing patients with type 2 diabetes: from lifestyle to insulin

The management of type 2 diabetes is multi-faceted. Following...

December 2015

Research Update: Testosterone use and cardiovascular risk in older males

In the previous edition of Best Practice Journal, we covered...

September 2015

A follow-up to acute coronary syndromes

The article: "The immediate management of acute coronary syndromes...

August 2015

The role of prophylactic antibiotics for preventing infective endocarditis in people undergoing dental or other minor procedures

Infective endocarditis is a relatively rare infection of the...

June 2015

An update on antithrombotic medicines - What does primary care need to know?

Antithrombotic medicines, such as aspirin and warfarin, have...

April 2015

The immediate management of acute coronary syndromes in primary care

The majority of patients who present to general practice with...

April 2015

News Update

Brand changes for cardiovascular medicines: carvedilol, ezetimibe...

April 2015

Dabigatran - An Update

This report provides an update on the use and monitoring of...

March 2015

The Year in Review - What did we learn in 2014?

In 2014 we published over 60 medical education articles in Best...

February 2015

Managing patients who are obese: Encouraging and maintaining healthy weight-loss

The mainstays of obesity management are simple and well known...

December 2014

News Updates

Medicines update: removal of Special Authority status | Antianginal...

October 2014

A review of statin use and monitoring

Statins are one of the most frequently prescribed medicines...

October 2014

Communicating cardiovascular risk effectively

Calculating a patient’s cardiovascular risk is relatively easy;...

September 2014

News Updates

Does aspirin protect against cancer? More high-quality research...

September 2014

Investigating myalgia in patients taking statins

Muscle pain (myalgia) and weakness is experienced by up to 10%...

August 2014

The ankle-brachial pressure index: An under-used tool in primary care?

Calculating a patient’s ankle-brachial pressure index (ABPI)...

April 2014

The year that was: Key messages from Best Practice Journal 2013

2013 began with publication of the 50th issue of Best Practice...

February 2014

“Oh and while you are here...”: Fasting may be unnecessary for lipid testing

A growing body of evidence and expert opinion suggests that...

November 2013

Hypertension in Adults: The silent killer

Hypertension is associated with a wide-range of cardiovascular...

August 2013

Ticagrelor – out with the old, in with the new?

Ticagrelor (Brilinta) is a new oral antiplatelet medicine, which...

August 2013

Giant cell arteritis: Always keep it in your head

Giant cell arteritis, also referred to as temporal arteritis,...

June 2013

Statins and the risk of acute kidney injury

THERE HAVE BEEN RECENT REPORTS in the literature associating...

April 2013

Identifying patients with heart failure in primary care

Heart failure is now described as either heart failure with...

February 2013

Managing patients with heart failure in primary care

Once heart failure has been diagnosed, the goal of treatment...

February 2013

Dabigatran revisited

Dabigatran has been available for general practitioners to prescribe...

February 2013

What your lipid test means for you

This A4 printable patient information sheet is designed to help...

December 2012

Assessing cardiovascular risk in people with high clinical risk factors

Cardiovascular risk assessment tools automatically adjust risk...

September 2012

Addressing weight issues in young people and families in New Zealand

New Zealand is one of the most overweight countries in the world....

August 2012

Looking back, looking forward: key messages 2005 – 2011

This report highlights four key prescribing and laboratory testing...

March 2012

Testing for CVD, diabetes and renal disease in elderly people

Consideration of laboratory testing and interpretation of subsequent...

March 2012

Updated data sheet for dabigatran etexilate

The dabigatran data sheet was updated in early November 2011...

December 2011

PHO Performance Programme - six years on

The PHO Performance Programme was established in 2005 to improve...

December 2011

Management of atrial fibrillation in general practice

Atrial fibrillation (AF) is often an incidental finding during...

October 2011

Medical management of stable angina pectoris

Patients presenting with symptoms consistent with angina is...

October 2011

The use of antithrombotic medicines in general practice: a consensus statement

In July 2011, a consensus forum was held in Wellington to discuss...

October 2011

Transient ischaemic attack: shoot first ask questions later

A transient ischaemic attack (TIA) is a medical emergency due...

October 2011

The medical management of stable angina

This web version is a sample only, all data below the national...

October 2011

The use of dabigatran in general practice

Dabigatran (Pradaxa) is now available in New Zealand, fully...

September 2011

News in brief: Maternity referral guidelines & Simvastatin


• New maternity referral guidelines released
• Simvastatin:...

September 2011

Cardiovascular disease risk assessment: what are the PHO Performance Programme indicators and how are they best achieved?

The PHO Performance Programme is a quality improvement initiative...

August 2011

Gout: an alarm bell for diabetes and cardiovascular disease

Counties Manukau DHB Māori Gout Action Group have identified...

August 2011

Raynaud's phenomenon: a whiter shade to winter's pale

Raynaud's phenomenon is a circulatory disorder, characterised...

August 2011

Rheumatic fever in Māori: what can we do better?

In New Zealand, acute rheumatic fever is now almost exclusively...

August 2011

News in brief: Dabigatran; Antibiotics and COC; Prescription kitchen

Dabigatran to be listed | Most broad spectrum antibiotics do...

June 2011

Should I still use both CRP and ESR when investigating temporal arteritis?

CRP alone is the best test for temporal arteritis. This...

March 2011

Assessing cardiovascular risk: what the experts think

Despite much being known about cardiovascular risk assessment,...

December 2010

Rheumatic fever - the neglected disease

New Zealand continues to have high rates of rheumatic fever,...

November 2010

Promoting healthy lifestyles for Pacific peoples

Ask a Pacific person what a healthy lifestyle means for them...

November 2010

Snippets: Jadelle & Sibutramine

Jadelle – A newly funded long-acting contraceptive implant |...

November 2010

Which Antihypertensive?

Once the decision has been made to initiate antihypertensive...

October 2010

Access to clopidogrel now widened

Clopidogrel, an antiplatelet medicine, is now able to be prescribed...

October 2010

Snippets: Insulin glargine & Ezetimibe

Insulin glargine – access widened from 1 August 2010 | Changes...

October 2010

The warfarin dilemma

Evidence suggests that warfarin is under utilised in older people....

October 2010

HbA1c targets in people with type 2 diabetes - do they matter?

Maintaining good glycaemic control reduces the risk of microvascular...

August 2010

Snippets: Iodine supplements Zoledronic acid & Atorvastatin


• Iodine supplements now funded
• Zoledronic acid now funded
• Atorvastatin...

August 2010

An update on statins

The decision to initiate a statin should be based upon an individual’s...

August 2010

Care of stroke survivors

The aim of stroke rehabilitation is for the patient to regain...

April 2010

Medicines for weight loss - do they work

Improving diet and increasing physical activity are the main...

April 2010

Time is brain: emergency treatment of stroke

Stroke is the third most common cause of death in New Zealand,...

March 2010

Secondary stroke prevention

People who have had a stroke or transient ischaemic attack are...

March 2010

Best Tests March 2010

Investigating the gut & Feedback on the Troponin & Urea...

March 2010

Best Tests


• The role of troponin testing in Primary Care
• Should we...

December 2009

The role of troponin testing in primary care

Troponins have overtaken the traditional ‘cardiac enzymes’,...

December 2009

Snippets: Aspirin for CVD & Paracetamol post-vaccination

Should aspirin still be used for primary prevention of cardiovascular...

December 2009

Upfront: Discussing weight loss in general practice

New Zealanders are getting fatter. That’s a fact. When a problem...

December 2009

Low molecular weight heparin use in primary care

Enoxaparin (Clexane) is a low molecular weight heparin used...

November 2009

Snippets: Nicotinic acid Fosamax Plus & Genetic testing

Nicotinic acid/laropiprant (Tredaptive) ▪ Fosamax Plus...

November 2009

Making a difference in chronic kidney disease

Mate tākihi ukiuki Chronic kidney disease affects approximately...

July 2009

One Heart Many Lives

He manawa takitahi, he iwi takitini “One Heart Many Lives”...

July 2009

What’s new in the 2009 New Zealand Cardiovascular Guidelines Handbook?

The New Zealand Guidelines Group recently released their updated...

June 2009

Drug monitoring - Monitoring diuretics in primary care

Monitoring a person on diuretics is necessary to assess response...

March 2009

The role of antiplatelet agents

Antiplatelet drugs including aspirin, clopidogrel and dipyrimadole,...

February 2009

Transient ischaemic attack - a medical emergency

For one in four people, transient ischaemic attack (TIA) is...

February 2009

Warfarin vs. aspirin for the prevention of atrial fibrillation related stroke

The decision whether to choose aspirin or warfarin for stroke...

February 2009

The management of anaphylaxis in primary care

Anaphylaxis is a potentially fatal hypersensitivity reaction,...

December 2008

The science behind lifestyle risk factors for cardiovascular disease

When advice is provided to patients about reducing cardiovascular...

December 2008

Metabolic syndrome: useful or not?

Debate about the clinical usefulness of a diagnosis of metabolic...

December 2008

Assessing cardiovascular disease risk

New PHO Performance indicators announced. GPs experiences of...

October 2008

Communicating cardiovascular risk - getting your message across

Many GPs find it difficult to explain CVD risk to their patients....

October 2008

Engaging patients in managing cardiovascular risk

Once a patient understands their CVD risk, the next step is...

October 2008

Patients understanding of cholesterol

A summary of the findings of a recent study which raises questions...

October 2008

Upfront: Cardiovascular risk screening

Professor Rod Jackson and Professor Simon Capewell debate screening...

October 2008

Cardiovascular disease and diabetes in Māori

Cardiovascular disease and type II diabetes are major causes...

May 2008

10 Minute tutorial

Creating a cardiovascular risk assessment alert in your PMS.

May 2008

Dilemmas: Managing cardiovascular risk in elderly people

Older people have a higher cardiovascular risk and therefore...

February 2008

Role of calcium channel blockers in hypertension

Thiazides are considered to be appropriate initial treatment...

December 2007

Snippets: Drug information of topical interest


• Calcium Supplementation and the risk of myocardial infarction
• Use...

December 2007

Lipid Testing for People with Cardiovascular Disease

November 2007

Laboratory Testing for Cardiovascular Risk

‘Laboratory Testing for Cardiovascular Risk’ is...

October 2007

Beta-blocker options following funding changes to Betaloc CR

Prescribing advice following changes to the funding of Betaloc...

September 2007

10 minute audit: Identifying your patients on colchicine

September 2007

Is carvedilol superior to metoprolol in heart failure?

Carvedilol may be an option for patients initiating beta-blocker...

September 2007

Upfront: co-enzyme Q10 supplements

“Would you like fries with that”. The role of co-enzyme...

September 2007

Dear Dave

Can Sumatriptan be used safely with SSRIs? Can you ever use...

August 2007

Dear Dave

What is the significance of the warning between ACE inhibitors...

June 2007

High Blood Pressure

Recent literature has raised doubts about the role of β-blockers...

June 2007

Opportunistic interventions in primary care can reduce stroke risk

Stroke is the third leading cause of death in New Zealand, after...

April 2007

Interactions with Warfarin

Warfarin has the potential to interact with numerous drugs resulting...

April 2007

Reminder: BNP, Haemochromatosis and Vitamin D

Key recommendations for BNP, Haemochromatosis and Vitamin D...

March 2007

Monitoring for metabolic disorders in patients taking antipsychotic drugs

This article is a brief overview of recommended monitoring for...

February 2007

Dear Dave

Can smoking cessation affect the dose of antipsychotics?Do statins...

February 2007

BNP Testing in Primary Care

from BNP/Haemochromatosis/Vitamin D: Testing in Primary CareThis...

January 2007

Amiodarone:- safety issues

Reducing adverse events in patients taking amiodarone.

December 2006

Warfarin

An update on treatment of atrial fibrillation with a focus on...

December 2006

INR testing

INR testing plus:
• Kōwhai tackles overdue INRs
• Oral route...

November 2006

Kōwhai tackles overdue INRs

INR testing plus:
• Kōwhai tackles overdue INRs
• Oral route...

November 2006

Excessive anticoagulation

INR testing plus:
• Kōwhai tackles overdue INRs
• Oral route...

November 2006

INR Testing

Warfarin is the most widely used anticoagulant in New Zealand....

October 2006

Guide for using INR to manage warfarin

Appendices from "INR Testing" including:
• Guide for using INR...

October 2006

Dear Dave

Is it safe to use beta-blockers for cardiac disease in people...

October 2006

NSAIDs and coxibs

Cardiovascular risk associated with NSAIDs and coxibsNSAIDs...

October 2006

ACE Inhibitors

This POEM is focused on the use of ACE Inhibitors in diabetes,...

April 2006

Best Tests: BNP

Thyroid function tests plus:
• eGFR
• BNP
• BRCA tests

December 2005

Diabetes

The diabetes POEMs focus on the drug treatment of adults with...

October 2004

Ischaemic cardiovascular disease

The purpose of the PHO Performance Programme is to reduce disparities...

June 2011

Made with by the bpacnz team